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affecting over 50% of men as they reach the 5th decade of
their life [1]. While over half of these patients have
symptoms, it is not clear why some of these men do while
others do not. The article Solving the benign prostatic hy-
perplasia puzzle by Keong Tatt Foo [2], delves into the
different conundrums urologists face when trying to treat
their patients. The purpose of this commentary is to bring
these issues to light to spur and guide further research
efforts.
First, why do some small prostates lead to bladder
outlet obstruction while some large prostates do not?
Sometimes the question is not how large the prostate is but
what is its shape and anatomy. Although we tend to
correlate lower urinary tract symptoms (LUTS) with benign
enlargement of the prostate (BPE), in practice it is not
uncommon to see patients with small prostates having se-
vere LUTS [3]. The adenoma can affect two zones: the
transitional and periurethral zone. The adenoma can then
give rise to different degrees of obstruction depending on
its location [3]. This can also occur with the subcervical
adenoma in patients with a small prostate which is located
below the bladder neck. This is not a bladder neck problem
in and over itself but can obstruct and cause LUTS. It is aPeer review under responsibility of Second Military Medical
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median lobe occurs when the prostatic adenoma (PA) is
situated in the periurethral zone and grows into the
bladder. This can create a “ball-valve” phenomenon lead-
ing to obstruction [4].
Grading of IPP. The most interesting puzzle refers to
grading of the intravesical prostatic protrusion (IPP). IPP
refers to “the distance in mm from the inner most tip of the
protrusion to the base of the prostate, at the circumference
of the bladder” [2]. Studies have found IPP to be effective
in diagnosing BPH and other obstructive problems [5,6]. IPP
grading can be utilized to predict failure rates in those with
urinary retention due to the correlation of “urodynamic
evidence of obstruction” and predict the clinical progres-
sion of BPH [2,7]. Lee et al. [8] evaluated the IPP as a
predictor of BPE. At total of 259 patients were treated to
LUTS secondary to BPE. IPP was graded as 1, 2 or 3. Fifty-
two patients had a clinical progression of BPE. A grade 2
IPP had an odds ratio of 5.1 and a grade 3 IPP was 10.4.
What is the relationship between clinical BPH and
LUTS? As we know, BPH is associated with LUTS. How-
ever, there are many men with BPH who do not have
significant LUTS. We often target the underlying BPH,
either medically or surgically, to alleviate cumbersome
symptoms of this condition [9,10]. However, there is a
poor association between PA obstruction and symptom
severity. In clinical practice, it is not appropriate to treat
patients based on a single symptom severity score, i.e.,
the International Prostate Symptom alone; the use of
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uncover the underlying issue [9].
Prostate specific antigen (PSA) does not increase with
age. There has been conflicting information regarding if
PSA increases with age. Evidence suggests men with no PA,
PSA remains in equilibrium and does not increase with age
in the absence of adenocarcinoma of the prostate. How-
ever, in men with no prostate cancer, different degrees of
PA can be associated with variable and fluctuating changes
in PSA.
In conclusion, there are many puzzles regarding the BPH
epidemic. By redefining the clinical definition of BPH, when
faced with these issues urologists have been able to treat
patients effectively when utilizing a variety of BPH treat-
ment options and being proactive in our approaches to
alleviating their symptoms.References
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